A 30 Day Acute Efficacy and Safety Study of Chromium Picolinate + Biotin on Glycemic Control in Overweight or Obese Subjects With T2DM
NACompletedINTERVENTIONAL
Enrollment
40
Participants
Timeline
Start Date
November 30, 2003
Study Completion Date
April 30, 2004
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG
Chromium Picolinate (600 mcg Cr+3) + biotin (2 mg)
Trial Locations (1)
60610
Radiant Research Chicago, Chicago
All Listed Sponsors
lead
Nutrition 21, Inc.
INDUSTRY
NCT00308451 - A 30 Day Acute Efficacy and Safety Study of Chromium Picolinate + Biotin on Glycemic Control in Overweight or Obese Subjects With T2DM | Biotech Hunter | Biotech Hunter